Why the study?
Does methylene blue pretreatment reduce propofol requirements during anaesthesia induction and surgery?
Does methylene blue pretreatment reduce propofol requirements during anaesthesia induction and surgery?
Methylene blue pretreatment significantly reduces intra-operative propofol requirements, necessitating careful titration of anaesthesia.
Methylene blue pretreatment may warrant propofol dose adjustment; leaves open confirmation of benefit or safety in randomized trials.
Delayed emergence from anaesthesia and neurological disturbances have been reported in patients undergoing parathyroidectomy who received methylene blue (MB) pre-operatively. We hypothesised that MB would decrease propofol requirements. The Bispectral index (BIS) and a target-controlled infusion of propofol were used in two groups of 11 matched patients. Patients in one group were pretreated with MB. During induction, clinical sedation scores and BIS values were significantly lower at the predicted effect-site propofol concentration of 2 microg x ml(-1) in the MB compared with the control group. Intra-operatively, although similar BIS values were achieved in the two groups, patients pretreated with MB required a mean 50% lower dose of propofol compared with controls. In view of these findings, care should be taken to ensure an adequate depth of anaesthesia by titrating the administration of anaesthetic agents whenever MB is infused peri-operatively.
No takes yet. Share an insight, caveat, or question.
Licker et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: